According to Shweta Maniar, Google Cloud’s director for healthcare and life sciences, real-world data (RWD) may speed up clinical trial and market access timelines for all forms of therapeutics. This advance is powered, Maniar argues, by the potential of RWD to empower decentralized clinical trials and replace placebo control groups. Digital health solutions can generate massive amounts of data that would otherwise be unfeasible to collect in standard centralized clinical trials.
According to Katie Adams, “Real-world data is collected remotely, so it also allows researchers to include more participants in their trials. A November PwC study showed that 67% of Americans said they were less likely to join in a clinical trial if they were required to travel outside their local area to get to the research site. This gives drugmakers and devicemakers the opportunity to take clinical trials out of hospitals and universities and into virtual settings.”
Click here to learn more.
(Source: Med City News, June 22nd, 2022)
